Deals
Catalyst Said to Take Therapure Public, Weighs Casino IPO
- Private equity firm to raise more than $75 million in IPO
- Mississauga-based Therapure focuses on biopharmaceuticals
This article is for subscribers only.
Catalyst Capital Group Inc., a Canadian private equity firm, is seeking to raise at least C$100 million ($75 million) in an initial public offering of Therapure Biopharma Inc., according to people familiar with the sale.
Catalyst, a Toronto-based firm founded by Newton Glassman, is also weighing an IPO of Gateway Casinos & Entertainment Ltd. in the next four to six weeks, said one of the people, who asked not to be identified because the information is private. Gateway, which operates in Western Canada, tried to do an IPO in 2012 but it was withdrawn.